NICE Guidance - October 2018
The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2018. This month there are two guidelines that impact upon primary care.
The Lyme disease guideline has been updated correcting the information relating to treatments for Lyme carditis in children aged 9 to 12 who are haemodynamically unstable.
The Decision-making and mental capacity guideline has been published. It covers decision-making in people 16 years and over who may lack capacity now or in the future. It aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so. It also helps practitioners to keep people who lack capacity at the centre of the decision-making process.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « Pregabalin and Gabapentin to be Controlled Drugs | CKS Updates - October 2018 » |
Hi, I love these updates, so handy! Just want to check, the text says 3 updates, but you only listed 2?
Comment by Rebecca Addyman — October 24, 2018 #
@Rebecca,
Thanks for proof reading and catching my failings. There are only two; I've updated the post accordingly.
Comment by Matthew Robinson — October 24, 2018 #